Stephen Boorjian, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Prokarium
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    Ferring
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    FerGene
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    ArTara
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    11/09/2022
Return to Update Series (2023) Lesson 1: Biochemical Recurrence of Prostate Cancer: Diagnosis, Risk Stratification, and Management